MP07-66

Artikelnummer	Größe	Manual	Lieferzeit	Preis
Cay42337-1	1 mg	-	6 - 10 Werktage*	73,00 €
Cay42337-5	5 mg	-	6 - 10 Werktage*	309,00 €
Cay42337-10	10 mg	-	6 - 10 Werktage*	473,00 €
Cay42337-25	25 mg	-	6 - 10 Werktage*	818,00 €

Bei Fragen nutzen Sie gerne unser Kontaktformular.
Bestellen Sie auch per E-Mail: info@biomol.com
Größere Menge gewünscht? Bulk-Anfrage

An inhibitor of the SET-PP2A protein-protein interaction, increases PP2A activity in isolated... mehr

Menü schließen

Produktinformationen "MP07-66"

An inhibitor of the SET-PP2A protein-protein interaction, increases PP2A activity in isolated human B-CLL cells at 3 and 8 µM, does not decrease plasma membrane S1P1 levels in isolated human B-CLL cells at 8 µM, induces apoptosis in isolated human B-CLL cells when used alone or in combination with dasatinib. Formulation: A solution in ethanol. InChI: InChI=1S/C19H33NO3/c1-4-7-8-9-14-23-18-12-10-17(11-13-18)15-20-16-19(21-5-2)22-6-3/h10-13,19-20H,4-9,14-16H2,1-3H3. InChIKey: WBCMPXCRPPCZSO-UHFFFAOYSA-N. SMILES: CCCCCCOC(C=C1)=CC=C1CNCC(OCC)OCC

Schlagworte:	N-(2,2-diethoxyethyl)-4-(hexyloxy)-benzenemethanamine
Hersteller:	Cayman Chemical
Hersteller-Nr:	42337

Eigenschaften

Anwendung:	SET (I2PP2A)-PP2A protein-protein interaction inhibitor
MW:	323.47 D
Formel:	C19H33NO3
Reinheit:	>98%
Format:	Solution

Datenbank Information

CAS :	1938056-90-6\| Passende Produkte
KEGG ID :	K11290 \| Passende Produkte

Handhabung & Sicherheit

Lagerung:	-20°C
Versand:	-20°C (International: -20°C)
Signalwort:	Danger
GHS-Piktogramme:
H-Sätze:	H225, H316, H319, H333
P-Sätze:	P210, P233, P240, P241, P242, P243, P264, P280, P303+361+353, P304+312, P305+351+338, P332+313, P337+313, P370+378, P403+235, P501